These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17299396)

  • 81. Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis.
    Hardee ME; Kirkpatrick JP; Shan S; Snyder SA; Vujaskovic Z; Rabbani ZN; Dewhirst MW; Blackwell KL
    Br J Cancer; 2005 Dec; 93(12):1350-5. PubMed ID: 16288305
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Relation of erythropoietin and erythropoietin receptor expression to hypoxia and anemia in head and neck squamous cell carcinoma.
    Winter SC; Shah KA; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
    Clin Cancer Res; 2005 Nov; 11(21):7614-20. PubMed ID: 16278379
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas.
    Hoogsteen IJ; Peeters WJ; Marres HA; Rijken PF; van den Hoogen FJ; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2005 Aug; 76(2):213-8. PubMed ID: 16112214
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Anemia, tumor hypoxemia, and the cancer patient.
    Varlotto J; Stevenson MA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):25-36. PubMed ID: 16111569
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models.
    Tóvári J; Gilly R; Rásó E; Paku S; Bereczky B; Varga N; Vágó A; Tímár J
    Cancer Res; 2005 Aug; 65(16):7186-93. PubMed ID: 16103069
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Quantitative evaluation and modeling of two-dimensional neovascular network complexity: the surface fractal dimension.
    Grizzi F; Russo C; Colombo P; Franceschini B; Frezza EE; Cobos E; Chiriva-Internati M
    BMC Cancer; 2005 Feb; 5():14. PubMed ID: 15701176
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia.
    Arcasoy MO; Amin K; Chou SC; Haroon ZA; Varia M; Raleigh JA
    Clin Cancer Res; 2005 Jan; 11(1):20-7. PubMed ID: 15671524
    [TBL] [Abstract][Full Text] [Related]  

  • 88. New avenues of exploration for erythropoietin.
    Maiese K; Li F; Chong ZZ
    JAMA; 2005 Jan; 293(1):90-5. PubMed ID: 15632341
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?
    Harrison L; Blackwell K
    Oncologist; 2004; 9 Suppl 5():31-40. PubMed ID: 15591420
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
    Jelkmann W; Wagner K
    Ann Hematol; 2004 Nov; 83(11):673-86. PubMed ID: 15322761
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Anaemia prior to operation is related with poorer long-term survival in patients with operable rectal cancer.
    van Halteren HK; Houterman S; Verheij CD; Lemmens VE; Coebergh JW
    Eur J Surg Oncol; 2004 Aug; 30(6):628-32. PubMed ID: 15256236
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts.
    Pinel S; Barberi-Heyob M; Cohen-Jonathan E; Merlin JL; Delmas C; Plenat F; Chastagner P
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):250-9. PubMed ID: 15093922
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hemoglobin levels during radiation therapy and their influence on local control and survival of patients with endometrial carcinoma.
    Münstedt K; Völzing M; Von Georgi R
    Oncol Rep; 2004 Mar; 11(3):711-7. PubMed ID: 14767527
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Tumor-line specific pO(2) fluctuations in human melanoma xenografts.
    Brurberg KG; Graff BA; Olsen DR; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):403-9. PubMed ID: 14751509
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast media.
    Pradel C; Siauve N; Bruneteau G; Clement O; de Bazelaire C; Frouin F; Wedge SR; Tessier JL; Robert PH; Frija G; Cuenod CA
    Magn Reson Imaging; 2003 Oct; 21(8):845-51. PubMed ID: 14599534
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.
    Henke M; Laszig R; Rübe C; Schäfer U; Haase KD; Schilcher B; Mose S; Beer KT; Burger U; Dougherty C; Frommhold H
    Lancet; 2003 Oct; 362(9392):1255-60. PubMed ID: 14575968
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival.
    Batra S; Perelman N; Luck LR; Shimada H; Malik P
    Lab Invest; 2003 Oct; 83(10):1477-87. PubMed ID: 14563949
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Human recombinant erythropoietin significantly improves tumor oxygenation independent of its effects on hemoglobin.
    Blackwell KL; Kirkpatrick JP; Snyder SA; Broadwater G; Farrell F; Jolliffe L; Brizel DM; Dewhirst MW
    Cancer Res; 2003 Oct; 63(19):6162-5. PubMed ID: 14559797
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Breast cancer trial with erythropoietin terminated unexpectedly.
    Leyland-Jones B;
    Lancet Oncol; 2003 Aug; 4(8):459-60. PubMed ID: 12901958
    [No Abstract]   [Full Text] [Related]  

  • 100. Erythropoietin regulates tumour growth of human malignancies.
    Yasuda Y; Fujita Y; Matsuo T; Koinuma S; Hara S; Tazaki A; Onozaki M; Hashimoto M; Musha T; Ogawa K; Fujita H; Nakamura Y; Shiozaki H; Utsumi H
    Carcinogenesis; 2003 Jun; 24(6):1021-9. PubMed ID: 12807756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.